Requirements for Patent Applications Containing Nucelotide

ICR 200111-0651-002

OMB: 0651-0024

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
IC Document Collections
ICR Details
0651-0024 200111-0651-002
Historical Active 200004-0651-005
DOC/PTO
Requirements for Patent Applications Containing Nucelotide
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 11/29/2001
Retrieve Notice of Action (NOA) 11/29/2001
  Inventory as of this Action Requested Previously Approved
09/30/2003 09/30/2003 08/31/2003
6,060 0 5,601
7,990 0 5,283
0 0 0

Rule 37 CFR 1.821-1.825 stipulate the use of a standard format for patent applicants to describe the nucleotide and/or amino acid sequence data within their patent applications. Under World Intellectual Property Organization (WIPO) Standard ST.25, sequence listings are presented in an international, language- neutral format using numeric identifiers rather than the format subject headings. The PTO uses this sequence listing information during the examination process to determine the patentability of an application, and after examination to support publication of issued patents. In addition, the sequences facilitate the

None
None


No

1
IC Title Form No. Form Name
Requirements for Patent Applications Containing Nucelotide

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 6,060 5,601 0 0 459 0
Annual Time Burden (Hours) 7,990 5,283 0 0 2,707 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
11/29/2001


© 2024 OMB.report | Privacy Policy